Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.570
+0.010 (0.39%)
At close: Apr 2, 2026, 4:00 PM EDT
2.409
-0.161 (-6.28%)
After-hours: Apr 2, 2026, 7:53 PM EDT
Genelux Market Cap
Genelux has a market cap or net worth of $114.04 million as of April 2, 2026. Its market cap has decreased by -16.41% in one year.
Market Cap
114.04M
Enterprise Value
101.13M
1-Year Change
-16.41%
Ranking
Category
Stock Price
$2.57
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $114.04M, a decrease of -19.52%. That is a compound annual growth rate of -6.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 114.04M | -30.47% |
| Dec 31, 2025 | 164.02M | 103.78% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
| Jan 26, 2023 | 141.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innate Pharma | 125.73M |
| Equillium | 124.56M |
| Sangamo Therapeutics | 124.32M |
| PepGen | 119.57M |
| NeOnc Technologies Holdings | 119.10M |
| AN2 Therapeutics | 117.53M |
| ProMIS Neurosciences | 112.19M |
| Biomea Fusion | 111.34M |